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Abstract
Background—Assessing pediatric patients for insulin resistance is one way to identify those
who are at a high risk of developing type 2 diabetes mellitus. The homoeostasis model assessment
(HOMA) is a measure of insulin resistance based on fasting blood glucose and insulin levels.
Although this measure is widely used in research, cutoff values for pediatric populations have not
been established.
Objective—To assess the validity of HOMA cutoff values used in pediatric studies published in
peer-reviewed journals.
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Methods—Studies published from January 2010 to December 2015 were identified through
MEDLINE. Initial screening of abstracts was done to select studies that were conducted in
pediatric populations and used HOMA to assess insulin resistance. Subsequent full-text review
narrowed the list to only those studies that used a specific HOMA score to diagnose insulin
resistance. Each study was classified as using a predetermined fixed HOMA cutoff value or a
cutoff that was a percentile specific to that population. For studies that used a predetermined cutoff
value, the references cited to provide evidence in support of that cutoff were evaluated.
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Results—In the 298 articles analyzed, 51 different HOMA cutoff values were used to classify
patients as having insulin resistance. Two hundred fifty-five studies (85.6%) used a predetermined
fixed cutoff value, but only 72 (28.2%) of those studies provided a reference that supported its use.
One hundred ten studies (43%) that used a fixed cutoff either cited a study that did not mention
HOMA or provided no reference at all. Tracing of citation history indicated that the most
commonly used cutoff values were ultimately based on studies that did not validate their use for
defining insulin resistance.
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Conclusion—Little evidence exists to support HOMA cutoff values commonly used to define
insulin resistance in pediatric studies. These findings highlight the importance of validating study
design elements when training medical students and novice investigators. Using available data to
generate population ranges for HOMA would improve its clinical utility.
Keywords
childhood obesity; diabetes; HOMA; insulin resistance
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With the increased prevalence of pediatric obesity, there has been much interest in the
development of clinical tools for identifying patients at the greatest risk for associated
comorbidities. Assessing patients for insulin resistance is one way to identify people who
are at a high risk for the development of type 2 diabetes mellitus. However, there is no
definitive assessment method, particularly in the pediatric population.1,2 The euglycemichyperinsulinemic glucose clamp technique is considered to be the criterion standard for
measurement of insulin resistance.3 However, this method is time consuming, expensive,
and invasive, as it requires infusion of insulin and repeated blood collection. The oral
glucose tolerance test (OGTT) is more commonly used to assess insulin resistance in clinical
practice and is recommended by the American Diabetes Association as an appropriate
screening tool for diabetes risk in asymptomatic adults and children with risk factors such as
obesity and family history of diabetes.4 However, this technique also requires multiple blood
collections and takes several hours to complete.3 Although measures derived from OGTT
data such as the Stumvoll metabolic clearance rate and the Matsuda index are believed to be
strong predictors of insulin resistance, less invasive and time-consuming methods would be
more useful for screening pediatric populations.5
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Several minimally invasive surrogate measures of insulin resistance using fasting glucose
and insulin levels have been developed.5 These surrogates are not included in current clinical
practice guidelines but are widely reported in the research literature.4 One of the most
commonly used measures is the homeostasis model assessment (HOMA) of insulin
resistance, which is calculated from fasting insulin and glucose levels (fasting insulin
[µIU/mL] × fasting glucose [mg/dL]/405). First introduced by Matthews et al6 in 1985,
HOMA has the advantage of requiring only a single fasting blood test. After its introduction,
many investigators began to use HOMA to assess insulin resistance in clinical and
epidemiologic studies. A review of these early studies provided recommendations regarding
HOMA use and interpretation.7 The recommendations included the importance of
establishing baseline values for different populations, but few large population studies have
been completed. Several studies comparing HOMA to euglycemic-hyperinsulinemic clamp
in adults have been published, but cutoff values for classifying patients as having insulin
resistance have not been clearly established.5,8,9 While similar studies have been done in the
pediatric population, establishing population norms and identifying HOMA cutoff values for
these patients has been further complicated by the increase in insulin resistance that occurs
naturally during puberty.2,10–14 The confusion surrounding the assessment of insulin
resistance was noted by Rössner et al15 in 2010, who reiterated the need to establish a
standard to avoid research waste. Unfortunately, this goal has not been accomplished, and
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investigators interested in assessing pediatric insulin resistance continue to use a variety of
approaches.2,16
In the absence of established HOMA cutoff values for defining insulin resistance in children,
some investigators have used a percentile specific to their study population, such as the top
quartile or greater than the 85th percentile, as a cut point.17–20 However, other investigators
have used predefined fixed cutoff values.21–23
The goal of this review was to assess the use of HOMA cutoff values in the pediatric
research literature, including which cutoffs are commonly used and the evidence supporting
use of those values. We hope that having a better understanding of how this marker is being
used will improve the quality of future research and provide additional impetus for
standardizing the assessment of insulin resistance in pediatric populations.
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Methods
Literature Search
A literature search was performed in October 2015 and covered studies published January 1,
2010, through the search date. An additional search was later performed to include research
published in November and December 2015. The search was limited to articles available in
the English language.
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The systematic search was conducted using MEDLINE and the following search strategy:
("insulin resistance"[mh] OR insulin resistan*[tiab] OR insulin sensitivity [tiab] OR
(resistan* AND insulin*[tiab]) OR metabolic syndr*[tiab])) AND ("Child"[mh:noexp] OR
"adolescent"[mh] OR "puberty"[mh:noexp] OR Pediatrics[mh:noexp] OR child[tiab] OR
children[tiab] OR adoles*[tiab] OR juvenile*[tiab] OR pediatr*[tiab] OR paediatr*[tiab]))
AND (HOMA[tiab] OR "homeostasis model assessment"[tiab] OR HOMA-IR[tiab]).
Screening
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Inclusion criteria during the initial review of abstracts were that study participants were aged
18 years or younger and that the study reported measurement of HOMA. Initial review of
abstracts was done by K.G.B., and excluded abstracts were divided and reviewed by C.F.,
L.B., or J.C. A third author who had not already reviewed the abstract made the final
decision on any abstracts for which the 2 initial reviewers did not agree. Subsequent review
of full-text articles for inclusion was done by C.F., L.B., and K.G.B. with disputed articles
reviewed by J.C. Inclusion criteria for the final analysis were confirmation that the study
population was aged 18 years or younger and a HOMA score cutoff was used to classify
patients as being insulin resistant or not. Studies in which HOMA score was only being
compared between groups or correlated to other factors with no use of a cutoff were
excluded from further analysis. Studies using HOMA to classify patients as having
metabolic syndrome and review articles or comments to the editor were also excluded.
Analysis
Full-text articles were evaluated for HOMA cutoffs used and evidence or citations
supporting the use of the cutoff in that population. Each study was classified as using a
J Am Osteopath Assoc. Author manuscript; available in PMC 2018 November 01.
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predetermined cutoff or a cutoff that was a percentile specific to that population (eg, >90th
percentile of HOMA in the study population or the top quartile of HOMA in the study
population). For studies using a predetermined cutoff, evidence supporting the use of that
cutoff was classified as follows:
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▪

No citation for the cutoff was provided.

▪

The citation referred to a study that used the same cutoff but did not validate the
cutoff.

▪

The references provided did not mention HOMA.

▪

The citation referred to a study that provided evidence supporting the use of the
cutoff in that population.

▪

The citation referred to a study that did not support the use of the cutoff in that
study population (eg, citing a study establishing pubertal cutoffs when the study
population was prepubertal, citing a study establishing cutoffs for the diagnosis
of metabolic syndrome).

Results
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A flowchart summarizing the literature search and screening results is shown in Figure 1. A
total of 1360 abstracts were screened for inclusion in the study. Of these abstracts, 424 were
excluded because they were not in the pediatric population or did not use HOMA to assess
insulin resistance. The remaining 936 full-text articles were obtained and assessed for
eligibility. Of these articles, 298 met the criteria for inclusion in the final analysis. Thirtyfour studies were excluded at the full-text screening stage because they included patients
older than 18 years, 5 were excluded because they were review articles or letters to the
editor, and 9 were excluded because they used HOMA to classify patients as having
metabolic syndrome. The remaining 590 articles were excluded because they measured
HOMA in children but did not use a cutoff to define insulin resistance. Examples included
comparing HOMA in different populations, tracking changes in response to an intervention,
and correlating HOMA to other factors, such as body mass index.24–26
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Among the 298 studies included in this review, 51 different HOMA cutoff values ranging
from 0.77 to 6.3 were used to classify patients as having insulin resistance (Figure 2). The
most frequently used values were 3.16 and 2.5. Forty-three studies (14.4%) used a percentile
cutoff specific to the study population. Of the 255 studies (85.6%) that used a predetermined
fixed cutoff to define insulin resistance, 72 (28.2%) provided a reference that supported the
use of that cutoff in the population. Forty-eight studies (18.8%) provided no reference for
their cutoff values, and 62 (24.3%) cited a study that was irrelevant (did not discuss
HOMA). Twenty-three articles (9%) cited a study that used the same cutoff value but did not
validate it. In addition, 50 studies (19.6%) cited a reference for the HOMA cutoff that
clearly did not support the use of that cutoff in their study population (Figure 3). For
example, several studies cited the 1985 study by Matthews et al6 to support the 2.5 cutoff for
defining insulin resistance. This study6 had a small population size, receiver operating
characteristic (ROC) curves were not generated, and the authors did not propose 2.5 as a
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cutoff for diagnosing insulin resistance. That number seems to reflect the study’s finding
that the median HOMA score for an overnight basal sample was 2.5 in the 6 adult diabetic
participants compared with 1.3 in the 6 nondiabetic participants.6
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The most commonly cited reference for the 3.16 cutoff was Keskin et al.13 This study
compared HOMA to OGTT in 57 pubertal obese children and adolescents. The ROC
analysis completed in that study identified 3.16 as the most appropriate cutoff in this
population. However, numerous studies cited this article as support for using 3.16 in
prepubertal populations despite the fact that insulin resistance is known to increase naturally
during puberty.10,11 The most commonly cited references for the 2.5 cutoff were Valerio et
al27 in 2006, Madeira et al28 in 2008, and Matthews et al.6 As described above, the study by
Matthews et al6 did not validate the use of 2.5 as a cutoff value in either adult or pediatric
populations. The study by Valerio et al27 reported the prevalence of insulin resistance in a
population of obese children and adolescents in southern Italy. In that study, 2.5 was used as
a cutoff for defining insulin resistance in children, and 4.0 was used as a cutoff for
adolescents, citing a 2004 study by D’Annunzio et al.29 Although the authors were
contacted, we have been unable to obtain this article. However, an abstract30 presentation
and a later article by the same group31 reveal the likelihood that these numbers were based
on percentiles of HOMA according to Tanner stage in a population of about 100 healthy
children. The study by Madeira et al28 used data from overweight prepubertal children to
identify HOMA cutoff values for predicting metabolic syndrome. Although metabolic
syndrome and insulin resistance are related, they are not equivalent. Using this study to
validate the 2.5 cutoff for diagnosing insulin resistance is not appropriate. Other studies that
attempted to establish HOMA cutoffs for identifying metabolic syndrome or assessing
cardiovascular risk were also cited by some groups as evidence to support their use in
diagnosing insulin resistance.32,33

Discussion
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Osteopathic medicine emphasizes the importance of disease prevention, which requires
appropriate screening to identify patients at the highest risk of disease development and
promote early intervention. Assessing obese and overweight pediatric patients for insulin
resistance is an approach that may be valuable for the prevention of diabetes and other
cardiometabolic diseases. However, standard methods for assessing insulin resistance in
children have not been established. In clinical and epidemiologic studies, HOMA is a
measurement frequently used to assess insulin sensitivity. Our current review of the pediatric
research literature identified a great degree of inconsistency in how HOMA is being used to
define insulin resistance and identified extremely limited evidence to support even the most
commonly used HOMA cutoff values. Although the difference between 2.5 and 3.16 may
not seem significant, the choice of a cutoff value can have a large impact when determining
the prevalence of insulin resistance in a population or identifying factors that contribute to its
development. For example, in our previous study34 of overweight and obese Appalachian
children, 82% of the patients would have been classified as insulin resistant using 2.5 as a
cutoff value, whereas the use of 3.16 would have resulted in a prevalence of 69%. These
differences greatly complicate comparisons between studies and impede the development of
practice guidelines.
J Am Osteopath Assoc. Author manuscript; available in PMC 2018 November 01.
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Although inconsistent use of HOMA cutoffs was not surprising, the finding that so few of
the selected cutoffs were supported by evidence was unexpected. More than 40% of the
articles that used a predetermined cutoff either had no reference for the cutoff or cited an
irrelevant study. Many authors simply cited a study that had used the same cutoff but did not
seem to review the previous work to ensure that the cutoff was valid for their study
population. When tracing back the citation history, many studies that selected 2.5 as a cutoff
were ultimately basing its use on the original study by Matthews et al,6 which described
HOMA as a measure of insulin resistance. This study clearly did not attempt to identify a
cutoff point, and it provides insufficient information to support widespread use of a specific
value for diagnosing insulin resistance in children or adults.
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Our findings cast doubt on the quality of study design and adequacy of peer review. Failure
to systematically review the literature before designing a study contributes to research waste.
35 This failure seems to be exhibited in the case of HOMA cutoff values. In the training of
novice investigators, the importance of working through a citation history to validate
elements of study design instead of simply following another group’s method should be
emphasized. This type of mentorship requires the continued support of research
opportunities for osteopathic medical students as we prepare them to advance osteopathicfocused research in the future.
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The findings of the current review are limited by the fact that other minimally invasive
surrogate measures of insulin resistance, such as the Quantitative Insulin Sensitivity Check
Index, were not included. It is possible that the evidence supporting cutoff values for those
indices is more substantial. Our review was also limited to articles available in the English
language and indexed in PubMed. This approach was used to ensure inclusion only of
articles published in journals that have been reviewed by the Literature Selection Technical
Review Committee to confirm that they follow best practices, including peer review.36
Additional evidence supporting the use of specific HOMA cutoffs may be available in
excluded journals or unpublished studies. However, as previously noted by Rössner et al,15
the absence of standard methods for assessing insulin resistance continues to complicate
interpretation of and comparisons between studies, thus contributing to research waste. The
need to choose a standard surrogate measure and then conduct large population studies to
establish sex- and age-specific ranges remains. Given the large number of published studies
that assessed HOMA in pediatric patients, it may be possible to generate population ranges
for HOMA or other fasting glucose and insulin-based surrogate measures through the
sharing of raw data. This approach is more likely to provide clinically useful information
than additional studies that compare HOMA or other surrogates with the OGTT or
euglycemic-hyperinsulinemic clamp.

Author Manuscript

Conclusion
Studies using HOMA to diagnose insulin resistance in children used a wide range of cutoff
values, most of which are not supported by evidence. These findings imply that inadequate
review of the literature before study design is not uncommon and emphasize the importance
of training new investigators to validate design components. The results also highlight the
need to standardize methods for assessing insulin resistance in children. Given the large
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number of studies in which HOMA was measured, it may be possible to generate sex- and
age-specific population ranges for HOMA or other surrogate measures based on insulin and
glucose levels through data sharing.
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Figure 1.

Flowchart of study selection in a review of pediatric literature in which homeostasis model
assessment (HOMA) cutoff values were used to diagnose insulin resistance.
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Figure 2.

Frequency and range of pediatric homeostasis model assessment (HOMA) cutoffs (N=298).
Fifty-one different cutoff values ranging from 0.77 to 6.3 were used. The most frequently
used cutoffs were 3.16 and 2.5.
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Figure 3.

Assessment of articles that used a fixed cutoff. The majority of studies used a predetermined
cutoff value to diagnose insulin resistance (n=255). Citations supporting the use of that
cutoff were subsequently evaluated.
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